Grifols (GIFLF) Change in Working Capital (2014 - 2020)
Grifols' (GIFLF) quarterly Change in Working Capital came in at -$66.3 million in Q1 2020, down 90.98% on a YoY basis from -$735.3 million in Q2 2019, and down 226.55% quarter-over-quarter from $52.4 million in Q4 2019.
Powered by 
Analysis
Grifols (GIFLF) Change in Working Capital (2014 - 2020) Analysis & Trends
Grifols (GIFLF) has reported Change in Working Capital for 6 consecutive years, with -$66.3 million the latest figure, recorded in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -66.31 Mn |
| Dec 31, 2019 | 52.39 Mn |
| Mar 31, 2019 | -34.72 Mn |
| Dec 31, 2018 | -2.12 Mn |
| Mar 31, 2018 | 11.92 Mn |
| Dec 31, 2017 | 71.33 Mn |
| Mar 31, 2017 | -22.48 Mn |
| Mar 31, 2015 | -195.16 Mn |
| Mar 31, 2014 | 120.25 Mn |